Clinical Trial Update: Prophylactic Donor Lymphocyte Infusion After Allo-PBSCT for Patients With Very High-risk Hematologic Malignancies [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on prophylactic donor lymphocyte infusion after allogeneic peripheral blood stem cell transplantation for very high-risk hematolog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• Decitabine (Decitabine)
• Donor Lymphocyte Infusion

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Donor Lymphocyte Infusion, Peripheral Blood Stem Cell Transplantation | Phase 2 | Status: UNKNOWN